meropenem

The objective is to evaluate the efficacy, safety, tolerance, and pharmacokinetics of intravenous meropenem in patients with cystic fibrosis experiencing an acute pulmonary exacerbation.

Research 2010

The purpose of this study is to determine the best dose and the safety of meropenem for the treatment of abdominal infections in infants more than 3 months of age.

Clinical Trials 2010

A multi-centered trial testing the effectiveness of a new antibiotic named meropenem in treating patients with a pulmonary exacerbation.

Research 2010

Evaluation of the efficacy, safety, tolerance, and pharmacokinetics of meropenem for the treatment of acute pulmonary exacerbations in patients with cystic fibrosis.

Research 2010

Hall: Yano et al. (12) recently reported that IMP-6, which differs from IMP-1 by a single amino acid substitution, increases the MIC of meropenem 128-fold but does not increase the resistance to imipenem.

Behe's Test, Take 2 2008

TP: Strains showing combined resistance to ceftazidime (MIC, 16 µg/ml), imipenem (MIC, 16 µg/ml), and meropenem (MIC, 16 µg/ml) were routinely screened for MβL genes by standards PCRs (2, 9, 11).

Behe's Test, Take 2 2008

The carbapenems, available since the 1970s, which include imipenem and meropenem among others.

SUPERBUG MARYN MCKENNA 2010

So the mechanismen is already documented for meropenem.

Behe's Test, Take 2 2008

The carbapenems, available since the 1970s, which include imipenem and meropenem among others.

SUPERBUG MARYN MCKENNA 2010

Strains showing combined resistance to ceftazidime (MIC, 16 µg/ml), imipenem (MIC, 16 µg/ml), and meropenem (MIC, 16 µg/ml) were routinely screened for MβL genes by standards PCRs (2, 9, 11).

Behe's Test, Take 2 2008